39.84
3.89%
1.49
Aligos Therapeutics Inc (ALGS) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
3.27%
0.694
|
0.672 | 1.085 | 4.294 | 0.14 |
Operating Expenses
|
19.69%
23.03
|
28.68 | 22.31 | 26.03 | 26.64 |
Benefits Costs and Expenses |
24.27%
35.53
|
28.59 | 19.10 | 22.33 | 23.06 |
Costs And Expenses |
24.27%
35.53
|
28.59 | 19.10 | 22.33 | 23.06 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
15.20%
-22.05
|
-26.00 | -19.07 | -19.14 | -23.92 |
Net Interest Income/Expense |
0.60
|
- | - | - | - |
Interest Income/Expense After Provision For Losses |
0.60
|
- | - | - | - |
Income/Loss From Continuing Operations Before Tax |
24.77%
-34.84
|
-27.92 | -18.01 | -18.03 | -22.92 |
Income Tax Expense/Benefit |
180.00%
0.024
|
-0.03 | 0.029 | 0.757 | 0.039 |
Income/Loss From Continuing Operations After Tax |
24.99%
-34.86
|
-27.89 | -18.04 | -18.79 | -22.95 |
Net Income/Loss
|
24.99%
-34.86
|
-27.89 | -18.04 | -18.79 | -22.95 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
641.79%
156.15
|
21.05 | 43.50 | 43.22 | 42.91 |
Diluted Average Shares |
641.79%
156.15
|
21.05 | 43.50 | 43.22 | 42.91 |
Basic Earnings Per Share |
1,200%
-0.22
|
0.02 | -0.41 | -0.43 | -0.53 |
Diluted Earnings Per Share |
1,200%
-0.22
|
0.02 | -0.41 | -0.43 | -0.53 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):